Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Dermatology

Date Submitted: Jun 26, 2025
Open Peer Review Period: Jun 30, 2025 - Aug 25, 2025
Date Accepted: Jan 16, 2026
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

AI and Digital Tools in Dermatology: Addressing Access and Misinformation

du Crest D, Madhumita M, Enbiale W, Ruiz Postigo JA, Malvehy J, Wongvibulsin S, Gupta S, Kittler H, Skayem C, Mahto A, Adamson A, Lipoff JB, Papier A, Cartier H, Garson S, Freeman E

AI and Digital Tools in Dermatology: Addressing Access and Misinformation

JMIR Dermatol 2026;9:e79044

DOI: 10.2196/79044

PMID: 41719483

PMCID: 12923100

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

AI and Digital Tools in Dermatology: Addressing Access and Misinformation in 2025

  • Dominique du Crest; 
  • Monisha Madhumita; 
  • Wendemagegn Enbiale; 
  • Jose Antonio Ruiz Postigo; 
  • Josep Malvehy; 
  • Shannon Wongvibulsin; 
  • Somesh Gupta; 
  • Harald Kittler; 
  • Charbel Skayem; 
  • Anjali Mahto; 
  • Adewole Adamson; 
  • Jules B. Lipoff; 
  • Art Papier; 
  • Hugues Cartier; 
  • Sébastien Garson; 
  • Esther Freeman

ABSTRACT

Digital dermatology is transforming access to skin care by addressing long-standing inequities related to geography, income, and skin type. As many as 70% of individuals with skin conditions do not receive professional care, creating an opportunity for digital tools - ranging from teledermatology and AI to large language models - to bridge gaps in diagnosis, education, and patient empowerment. However, these innovations could worsen existing disparities if not designed intentionally, due to algorithmic bias, unequal digital access, and a lack of culturally responsive models. This paper examines digital dermatology's potential to promote equitable care by focusing on three critical areas: broadening access via digital platforms, ensuring AI fairness through comprehensive datasets, and combating dermatological misinformation using expert-led, AI-powered communication strategies, including a conceptual chatbot that synthesizes and prioritizes dermatologic science for practical use. Drawing on global case studies and insights from the WHO’s AI skin health app and the Skin and Digital Summit, we underscore both the transformative potential and ethical complexities of deploying digital solutions. We advocate for a Radical Dermatology framework that integrates technological advances with community-centered care, equitable data practices, and collaborative design. This vision calls for dermatologists to take the lead, combining scientific rigor with digital innovation to cultivate a more inclusive, intelligent, and trustworthy skin health ecosystem.


 Citation

Please cite as:

du Crest D, Madhumita M, Enbiale W, Ruiz Postigo JA, Malvehy J, Wongvibulsin S, Gupta S, Kittler H, Skayem C, Mahto A, Adamson A, Lipoff JB, Papier A, Cartier H, Garson S, Freeman E

AI and Digital Tools in Dermatology: Addressing Access and Misinformation

JMIR Dermatol 2026;9:e79044

DOI: 10.2196/79044

PMID: 41719483

PMCID: 12923100

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.